Register entryShortage reported

Cumberland Pharmaceuticals Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
7
Live patents
0
Shortage listings
1
Countries
0
Alert

Drug shortage listings

1
DrugPresentationStatusAvailabilityPosted / updated
Conivaptan Hydrochloride InjectionCardiovascularVaprisol Dextrose In Plastic Container, Injection, 20 mg/100 mL (NDC 66220-160-10)CurrentUnavailable14 Mar 202216 Sept 2026
Catalogue

Drug listings by form and route

7

7 active NDC listings: 7 human prescription drug. By marketing category: NDA 5, ANDA 2.

Dosage formNDCs
injection2
powder, for solution2
injection, powder, lyophilized, for solution1
injection, solution1
patch1
RouteNDCs
intravenous4
oral2
transdermal1
Labeller name on the listingNDCs
cumberland pharmaceuticals inc.7
Catalogue

Marketed products

7
BrandGeneric nameForm / routeNDC
ACETADOTEAcetylcysteineinjection, solution, intravenous66220-207NDA
Caldoloribuprofeninjection, intravenous66220-284NDA
Caldoloribuprofeninjection, intravenous66220-287NDA
KRISTALOSElactulosepowder, for solution, oral66220-719ANDA
KRISTALOSElactulosepowder, for solution, oral66220-729ANDA
SANCUSOgranisetronpatch, transdermal66220-637NDA
VIBATIVtelavancin hydrochlorideinjection, powder, lyophilized, for solution, intravenous66220-315NDA
Compare

Other companies listing ibuprofen

Enquiry

Common questions

Is Cumberland Pharmaceuticals Inc. FDA approved?
Cumberland Pharmaceuticals Inc. holds no registered establishment of its own; 7 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Cumberland Pharmaceuticals Inc. make?
7 products are listed under Cumberland Pharmaceuticals Inc. in the openFDA NDC Directory, most often as injection; powder, for solution; injection, powder, lyophilized, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Are any Cumberland Pharmaceuticals Inc. products in shortage?
1 presentation is currently listed in the FDA drug shortage database under Cumberland Pharmaceuticals Inc., covering Conivaptan Hydrochloride Injection.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.